)
Single-dose Johnson & Johnson Coronavirus vaccine shows 66% efficacy
Johnson & Johnson Coronavirus vaccine has shown an overall 66% efficacy in preventing moderate to severe COVID-19. Although the trial results indicate that it is less effective against the virus variant first discovered in South Africa.
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)